Scalper1 News
Generic-drug maker Mylan (MYL) raised its offer for drugstore supplier Perrigo on Wednesday, but got rejected again. Mylan offered $75 a share in cash plus 2.3 Mylan shares for each Perrigo (PRGO) share, a significant increase from its April 24 bid of $60 in cash plus 2.2 Mylan shares. Based on Mylan’s share price on April 8, when it first proposed buying Perrigo, this most recent offer comes out to $232.23 per Perrigo share, or $35.6 billion. Scalper1 News
Scalper1 News